BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 7543605)

  • 21. Evaluation of the clinical performance of equimolar- and skewed-response total prostate-specific antigen assays versus complexed and free PSA assays and their ratios in discriminating between benign prostatic hyperplasia and prostate cancer.
    Wians FH; Cheli CD; Balko JA; Bruzek DJ; Chan DW; Sokoll LJ
    Clin Chim Acta; 2002 Dec; 326(1-2):81-95. PubMed ID: 12417099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percent free prostate-specific antigen: entering a new era in the detection of prostate cancer.
    Vashi AR; Oesterling JE
    Mayo Clin Proc; 1997 Apr; 72(4):337-44. PubMed ID: 9121181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate specific antigen complexed to alpha-1-antichymotrypsin in patients with intermediate prostate specific antigen levels.
    Saika T; Tsushima T; Nasu Y; Kusaka N; Miyaji Y; Takamoto H; Takeda K; Uno S; Kumon H;
    Cancer; 2002 Mar; 94(6):1685-91. PubMed ID: 11920529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-related reference levels of serum prostate-specific antigen among Taiwanese men without clinical evidence of prostate cancer.
    Lin KJ; Pang ST; Chang YH; Wu CT; Chuang KL; Chuang HC; Chuang CK
    Chang Gung Med J; 2010; 33(2):182-7. PubMed ID: 20438671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Free and complexed prostate-specific antigen serum ratios to predict probability of primary prostate cancer and benign prostatic hyperplasia.
    Marley GM; Miller MC; Kattan MW; Zhao G; Patton KP; Vessella RL; Wright GL; Schellhammer PF; Veltri RW
    Urology; 1996 Dec; 48(6A Suppl):16-22. PubMed ID: 8973695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
    Bangma CH; Kranse R; Blijenberg BG; Schröder FH
    Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: relationship to transition zone volume.
    Stamey TA; Yemoto CE
    J Urol; 2000 Jan; 163(1):119-26. PubMed ID: 10604328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Status of PSA determination for early detection of prostate carcinoma].
    Hammerer P; Huland H
    Versicherungsmedizin; 1995 Jun; 47(3):83-6. PubMed ID: 7541925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Values for free/total prostate-specific antigen ratio as a function of age: necessity of reference validation in a Turkish population.
    Mungan AG; Erol B; Akduman B; Bozdogan G; Kiran S; Yesilli C; Mungan NA
    Clin Chem Lab Med; 2007; 45(7):912-6. PubMed ID: 17617037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2 to 4 ng/ml.
    Catalona WJ; Bartsch G; Rittenhouse HG; Evans CL; Linton HJ; Amirkhan A; Horninger W; Klocker H; Mikolajczyk SD
    J Urol; 2003 Dec; 170(6 Pt 1):2181-5. PubMed ID: 14634374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the clinical value of complexed PSA and total PSA in the discrimination between benign prostatic hyperplasia and prostate cancer.
    Froehner M; Hakenberg OW; Koch R; Schmidt U; Meye A; Wirth MP
    Urol Int; 2006; 76(1):27-30. PubMed ID: 16401917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
    Steuber T; Nurmikko P; Haese A; Pettersson K; Graefen M; Hammerer P; Huland H; Lilja H
    J Urol; 2002 Nov; 168(5):1917-22. PubMed ID: 12394676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethnic differences in distribution of serum prostate-specific antigen: a study in a healthy Chinese male population.
    He D; Wang M; Chen X; Gao Z; He H; Zhau HE; Wang W; Chung LW; Nan X
    Urology; 2004 Apr; 63(4):722-6. PubMed ID: 15072888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The proportion of prostate-specific antigen (PSA) complexed to alpha(1)-antichymotrypsin improves the discrimination between prostate cancer and benign prostatic hyperplasia in men with a total PSA of 10 to 30 microg/L.
    Martínez M; España F; Royo M; Alapont JM; Navarro S; Estellés A; Aznar J; Vera CD; Jiménez-Cruz JF
    Clin Chem; 2002 Aug; 48(8):1251-6. PubMed ID: 12142381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer.
    Ellis WJ; Etzioni R; Vessella RL; Hu C; Goodman GE
    J Urol; 2001 Jul; 166(1):93-8; discussion 98-9. PubMed ID: 11435831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men.
    Cooney KA; Strawderman MS; Wojno KJ; Doerr KM; Taylor A; Alcser KH; Heeringa SG; Taylor JM; Wei JT; Montie JE; Schottenfeld D
    Urology; 2001 Jan; 57(1):91-6. PubMed ID: 11164150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older.
    Oesterling JE; Jacobsen SJ; Cooner WH
    J Urol; 1995 Apr; 153(4):1160-3. PubMed ID: 7532725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparisons of the various combinations of free, complexed, and total prostate-specific antigen for the detection of prostate cancer.
    Okegawa T; Noda H; Nutahara K; Higashihara E
    Eur Urol; 2000 Oct; 38(4):380-7. PubMed ID: 11025374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of prostate-specific antigen in the evaluation of benign prostatic hyperplasia.
    Tchetgen MB; Oesterling JE
    Urol Clin North Am; 1995 May; 22(2):333-44. PubMed ID: 7539179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate-specific antigen complexed to alpha(1)-antichymotrypsin in the early detection of prostate cancer.
    Martínez M; España F; Royo M; Vera CD; Estellés A; Jiménez-Cruz JF; Medina P; Aznar J
    Eur Urol; 2000 Jul; 38(1):85-90. PubMed ID: 10859447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.